.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Chikungunya virus (CHIKV) continues to pose a severe public health challenge globally, including in India. Currently, no specific vaccine or Chikungunya antiviral treatment exists for clinical use. Researchers are therefore investigating novel synthetic compounds to fill this therapeutic gap. A recent study has highlighted bis-naphthoquinone (H-5) as a particularly promising candidate due to its high efficacy and safety profile.
The investigation utilized various cellular and animal models to evaluate the potency of H-5. Laboratory tests revealed that the compound has a low cytotoxicity (CC50) of 1103 μM. Meanwhile, its antiviral activity (EC50) reached a significant level of 0.96 μM. Consequently, H-5 demonstrates a wide therapeutic window. Furthermore, time-of-addition experiments confirmed that the drug effectively inhibits the viral replication cycle. Additionally, the study explored combination therapy. Results showed a strong synergistic effect when researchers combined H-5 with Ribavirin. This interaction could potentially lead to more effective clinical outcomes using lower drug dosages.
Beyond laboratory cultures, H-5 showed considerable potential in mouse models. The compound significantly reduced edema and induced favorable histological changes in infected tissues. Therefore, these findings suggest that H-5 is a robust candidate for a Chikungunya antiviral treatment. Nevertheless, further clinical trials are necessary to confirm these results in human patients. Medical professionals should monitor these developments closely, as they represent a major advancement in managing arboviral infections.
Currently, there is no specific antiviral treatment for Chikungunya. H-5 is a novel synthetic compound that specifically targets viral replication with high potency and low toxicity, unlike current symptomatic care.
The strong synergistic effect suggests that combining H-5 with Ribavirin can enhance antiviral efficacy. This synergy potentially allows for lower therapeutic doses and reduced side effects in future treatment regimens.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Clinical decisions should be made by qualified healthcare professionals. Refer to the latest local and national guidelines for clinical practice.
References
Gomes MWL et al. Antiviral Activity of Synthetic Bis-Naphthoquinone (H-5) against Chikungunya Virus Replication. Curr Top Med Chem. 2026 Apr 06. doi: 10.2174/0115680266358458251009100413. PMID: 41944112.
World Health Organization. Chikungunya Fact Sheet. 2023.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Study reveals the high antiviral potential of synthetic bis-naphthoquinone (H-5) against Chikungunya, showing low toxicity and synergistic effects....
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
